112 Another study demonstrated the formation of a disease-specific strain of aggregated α-synuclein different from the one occurring in Parkinson’s disease.113 These studies suggest the importance and necessity to better understand the occurrence and the difference between strains of these amyloidogenic proteins in various clinical subtypes of AD pathology. This evidence concerns the gene SNCA and Parkinson disease.